PCN57 Budget IMPACT Analysis of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapie ...

Abstract

Authors

G. Gourzoulidis M. Koulentaki A. Koumarianou E. Samantas N. Androulakis S. Xynogalos P. Papakotoulas I. Boukovinas M. Karamouzis I. Souglakos V. Chotzagiannoglou A. Beletsi G. Kourlaba

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×